- Home
- BIVI vs CODX Comparison
BIVI vs CODX Comparison
Compare BIVI & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- CODX
- Stock Information
- Founded
- BIVI 2013
- CODX 2013
- Country
- BIVI United States
- CODX United States
- Employees
- BIVI N/A
- CODX N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- CODX Medical/Dental Instruments
- Sector
- BIVI Health Care
- CODX Health Care
- Exchange
- BIVI Nasdaq
- CODX Nasdaq
- Market Cap
- BIVI 18.8M
- CODX 22.0M
- IPO Year
- BIVI N/A
- CODX 2017
- Fundamental
- Price
- BIVI $0.85
- CODX $0.36
- Analyst Decision
- BIVI Strong Buy
- CODX Hold
- Analyst Count
- BIVI 1
- CODX 1
- Target Price
- BIVI $30.00
- CODX $1.00
- AVG Volume (30 Days)
- BIVI 204.2K
- CODX 202.3K
- Earning Date
- BIVI 05-13-2025
- CODX 05-08-2025
- Dividend Yield
- BIVI N/A
- CODX N/A
- EPS Growth
- BIVI N/A
- CODX N/A
- EPS
- BIVI N/A
- CODX N/A
- Revenue
- BIVI N/A
- CODX $3,915,160.00
- Revenue This Year
- BIVI N/A
- CODX N/A
- Revenue Next Year
- BIVI N/A
- CODX N/A
- P/E Ratio
- BIVI N/A
- CODX N/A
- Revenue Growth
- BIVI N/A
- CODX N/A
- 52 Week Low
- BIVI $0.62
- CODX $0.28
- 52 Week High
- BIVI $7.50
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- BIVI 43.28
- CODX 42.21
- Support Level
- BIVI $0.75
- CODX $0.32
- Resistance Level
- BIVI $0.88
- CODX $0.38
- Average True Range (ATR)
- BIVI 0.11
- CODX 0.05
- MACD
- BIVI 0.02
- CODX 0.01
- Stochastic Oscillator
- BIVI 81.78
- CODX 60.87
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.